CY1117480T1 - Χρηση ενωσεων εστερα υδροξυβενζοϊκου οξεος για την κατασκευη ενος φαρμακου για την προληψη και θεραπευτικη αγωγη λοιμωξης απο hpv - Google Patents
Χρηση ενωσεων εστερα υδροξυβενζοϊκου οξεος για την κατασκευη ενος φαρμακου για την προληψη και θεραπευτικη αγωγη λοιμωξης απο hpvInfo
- Publication number
- CY1117480T1 CY1117480T1 CY20161100272T CY161100272T CY1117480T1 CY 1117480 T1 CY1117480 T1 CY 1117480T1 CY 20161100272 T CY20161100272 T CY 20161100272T CY 161100272 T CY161100272 T CY 161100272T CY 1117480 T1 CY1117480 T1 CY 1117480T1
- Authority
- CY
- Cyprus
- Prior art keywords
- prevention
- treatment
- hydroxybenic
- construction
- acid compounds
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title abstract 2
- 208000009608 Papillomavirus Infections Diseases 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000010276 construction Methods 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- -1 hydroxybenzoic acid ester Chemical class 0.000 abstract 2
- 230000009385 viral infection Effects 0.000 abstract 2
- 208000009889 Herpes Simplex Diseases 0.000 abstract 1
- 206010037742 Rabies Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 206010009887 colitis Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000003628 erosive effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Cardiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Detergent Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100122870A CN100427082C (zh) | 2005-08-02 | 2005-08-02 | 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用 |
| EP06761527.8A EP1930002B1 (en) | 2005-08-02 | 2006-07-21 | Use of hydroxybenzoic acid ester compounds for the manufacture of a medicament for the prevention and treatment of hpv infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1117480T1 true CY1117480T1 (el) | 2017-04-26 |
Family
ID=37698614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20161100272T CY1117480T1 (el) | 2005-08-02 | 2016-04-05 | Χρηση ενωσεων εστερα υδροξυβενζοϊκου οξεος για την κατασκευη ενος φαρμακου για την προληψη και θεραπευτικη αγωγη λοιμωξης απο hpv |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1930002B1 (enExample) |
| JP (1) | JP5473328B2 (enExample) |
| KR (1) | KR100922605B1 (enExample) |
| CN (1) | CN100427082C (enExample) |
| AP (1) | AP2658A (enExample) |
| AU (1) | AU2006275232B2 (enExample) |
| BR (1) | BRPI0616536B8 (enExample) |
| CA (1) | CA2617659C (enExample) |
| CY (1) | CY1117480T1 (enExample) |
| DK (1) | DK1930002T3 (enExample) |
| EA (1) | EA016576B1 (enExample) |
| ES (1) | ES2567130T3 (enExample) |
| HU (1) | HUE027244T2 (enExample) |
| IL (1) | IL189162A (enExample) |
| MX (1) | MX2008001673A (enExample) |
| NZ (1) | NZ566153A (enExample) |
| PL (1) | PL1930002T3 (enExample) |
| SI (1) | SI1930002T1 (enExample) |
| UA (1) | UA90159C2 (enExample) |
| WO (1) | WO2007014515A1 (enExample) |
| ZA (1) | ZA200801635B (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102603522B (zh) * | 2011-01-23 | 2015-04-22 | 复旦大学 | 苯酚类衍生物及其在制备抗乙肝病毒药物中的用途 |
| KR101401154B1 (ko) * | 2011-02-22 | 2014-05-30 | 경희대학교 산학협력단 | 메틸 갈레이트를 포함하는 조절 ｔ 세포 활성 억제용 약학적 조성물 |
| PL404138A1 (pl) * | 2013-05-31 | 2014-12-08 | Warszawski Uniwersytet Medyczny | Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα |
| CN103599093B (zh) | 2013-11-18 | 2016-06-01 | 中国医学科学院生物医学工程研究所 | 一种抗hpv药物制剂及用途 |
| CN103948729B (zh) * | 2014-05-15 | 2015-09-09 | 陈欣 | 一种治疗宫颈糜烂的中药栓剂及其制备方法 |
| CA3008466C (en) | 2015-12-18 | 2023-06-20 | Talengen International Limited | Method for preventing or treating radiation and chemical damage |
| EP3395355B1 (en) * | 2015-12-18 | 2026-03-04 | Talengen International Limited | Plasminogen for use in treating cervical erosion |
| CN105748506B (zh) * | 2016-03-03 | 2018-08-17 | 青岛海洋生物医药研究院股份有限公司 | 褐藻酸硫酸酯在制备预防和治疗由人乳头瘤状病毒引起的疾病的药物和保健品中的应用 |
| JPWO2019087884A1 (ja) * | 2017-10-31 | 2020-11-19 | 富士フイルム株式会社 | 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
| JPWO2019087881A1 (ja) * | 2017-10-31 | 2020-10-22 | 富士フイルム株式会社 | 抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
| JPWO2019087888A1 (ja) * | 2017-10-31 | 2020-11-12 | 富士フイルム株式会社 | 組成物、抗菌組成物、抗ウイルス用組成物、抗ノロウイルス用組成物、スプレー、ワイパー |
| CN111419833B (zh) * | 2020-06-02 | 2023-04-07 | 上海爱启医药技术有限公司 | 没食子酸的药物应用 |
| CN114146078B (zh) * | 2020-09-07 | 2025-09-16 | 盈科瑞（横琴）药物研究院有限公司 | 对羟基苯甲酸乙酯抗冠状病毒感染的应用 |
| CN114146082B (zh) * | 2020-09-07 | 2025-09-05 | 盈科瑞（横琴）药物研究院有限公司 | 对羟基苯甲酸甲酯及其钠盐抗冠状病毒的用途 |
| CN112375803B (zh) * | 2020-11-16 | 2024-05-07 | 石河子大学 | 五倍子中抗炎活性成分没食子酸乙酯的筛选方法及其用途 |
| CN118489806A (zh) * | 2024-05-13 | 2024-08-16 | 浙江大学 | 多酚在制备预防和/或缓解动物锌过载所致肠道免疫应激或肠道损伤制剂中的应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3929985A (en) * | 1974-01-18 | 1975-12-30 | Richardson Merrell Inc | Anhydrous candicidin foam compositions |
| JPS62132824A (ja) * | 1985-12-05 | 1987-06-16 | Eisai Co Ltd | 肝炎への治療剤 |
| SE464167B (sv) * | 1989-07-31 | 1991-03-18 | Analytecon Sa | Topisk farmaceutisk beredning av podophyllotoxin |
| CN1042298C (zh) * | 1989-07-31 | 1999-03-03 | 安纳利蒂康有限公司 | 含鬼臼毒的乳膏形式的药物组合物的制备方法 |
| CN1068782A (zh) * | 1992-01-30 | 1993-02-10 | 展静 | 轮胎气压报警装置 |
| NL9500216A (nl) * | 1995-02-06 | 1996-09-02 | Bio Pharma Sciences Bv | Farmaceutische samenstelling voor de behandeling van herpes. |
| DE19514694A1 (de) * | 1995-04-13 | 1996-10-17 | Ina Dr Levi | Breitspektrum-Antiinfektivamittel |
| JPH0959151A (ja) * | 1995-08-24 | 1997-03-04 | Kao Corp | ＮＦ−κＢ活性化抑制剤 |
| CN1068782C (zh) * | 1996-04-18 | 2001-07-25 | 中国医药研究开发中心 | 以栾树提取物为有效组分的抗癌药物及制备方法 |
| JPH09328404A (ja) * | 1996-06-07 | 1997-12-22 | Iwao Hishida | 殺菌、抗菌および不活化剤 |
| TW536403B (en) * | 1997-03-24 | 2003-06-11 | Glaxo Group Ltd | An ethanol and ethylenediaminetetraacetic acid free pharmaceutical composition comprising lamivudine and exhibiting antimicrobial preservative efficacy |
| KR20010013377A (ko) | 1997-06-04 | 2001-02-26 | 데이비드 엠 모이어 | 마일드한 잔류성 항균 조성물 |
| DK1383512T3 (da) * | 2001-05-03 | 2004-11-15 | Farmigea Spa | Anvendelse af sucralfat til behandling af cervikal erosion |
-
2005
- 2005-08-02 CN CNB2005100122870A patent/CN100427082C/zh not_active Expired - Lifetime
-
2006
- 2006-07-21 JP JP2008524341A patent/JP5473328B2/ja not_active Expired - Lifetime
- 2006-07-21 EP EP06761527.8A patent/EP1930002B1/en not_active Expired - Lifetime
- 2006-07-21 BR BRPI0616536A patent/BRPI0616536B8/pt not_active IP Right Cessation
- 2006-07-21 SI SI200632042A patent/SI1930002T1/sl unknown
- 2006-07-21 EA EA200800467A patent/EA016576B1/ru unknown
- 2006-07-21 AP AP2008004351A patent/AP2658A/xx active
- 2006-07-21 KR KR1020087005140A patent/KR100922605B1/ko not_active Expired - Fee Related
- 2006-07-21 CA CA2617659A patent/CA2617659C/en not_active Expired - Lifetime
- 2006-07-21 PL PL06761527T patent/PL1930002T3/pl unknown
- 2006-07-21 DK DK06761527.8T patent/DK1930002T3/en active
- 2006-07-21 MX MX2008001673A patent/MX2008001673A/es active IP Right Grant
- 2006-07-21 NZ NZ566153A patent/NZ566153A/en not_active IP Right Cessation
- 2006-07-21 UA UAA200802626A patent/UA90159C2/ru unknown
- 2006-07-21 AU AU2006275232A patent/AU2006275232B2/en not_active Ceased
- 2006-07-21 ES ES06761527.8T patent/ES2567130T3/es not_active Expired - Lifetime
- 2006-07-21 WO PCT/CN2006/001792 patent/WO2007014515A1/zh not_active Ceased
- 2006-07-21 HU HUE06761527A patent/HUE027244T2/en unknown
-
2008
- 2008-01-31 IL IL189162A patent/IL189162A/en active IP Right Grant
- 2008-02-19 ZA ZA200801635A patent/ZA200801635B/xx unknown
-
2016
- 2016-04-05 CY CY20161100272T patent/CY1117480T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2567130T3 (es) | 2016-04-20 |
| KR100922605B1 (ko) | 2009-10-21 |
| EA200800467A1 (ru) | 2008-10-30 |
| HK1113747A1 (en) | 2008-10-17 |
| IL189162A0 (en) | 2008-08-07 |
| SI1930002T1 (sl) | 2016-06-30 |
| BRPI0616536A2 (pt) | 2012-12-25 |
| WO2007014515A1 (en) | 2007-02-08 |
| BRPI0616536B8 (pt) | 2021-05-25 |
| HUE027244T2 (en) | 2016-09-28 |
| CA2617659A1 (en) | 2007-02-08 |
| AU2006275232B2 (en) | 2010-12-02 |
| BRPI0616536B1 (pt) | 2020-05-26 |
| MX2008001673A (es) | 2008-11-06 |
| EA016576B1 (ru) | 2012-06-29 |
| DK1930002T3 (en) | 2016-04-11 |
| PL1930002T3 (pl) | 2016-07-29 |
| EP1930002A1 (en) | 2008-06-11 |
| CN1907276A (zh) | 2007-02-07 |
| NZ566153A (en) | 2011-07-29 |
| KR20080036128A (ko) | 2008-04-24 |
| ZA200801635B (en) | 2009-06-24 |
| JP2009502985A (ja) | 2009-01-29 |
| CN100427082C (zh) | 2008-10-22 |
| UA90159C2 (ru) | 2010-04-12 |
| EP1930002A4 (en) | 2010-04-21 |
| AP2658A (en) | 2013-05-09 |
| AU2006275232A1 (en) | 2007-02-08 |
| IL189162A (en) | 2014-04-30 |
| JP5473328B2 (ja) | 2014-04-16 |
| CA2617659C (en) | 2013-02-26 |
| EP1930002B1 (en) | 2016-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2470016C2 (ru) | Производное бипиразола | |
| RU2329050C2 (ru) | Комбинация ингибиторов цитохром-р450-зависимых протеаз | |
| CY1107302T1 (el) | Χρηση ρεσβερατρολης για την παρασκευη ενος φαρμακου που ειναι χρησιμο για τη θεραπεια λοιμωξεων απο τον ιο της γριπης | |
| RU2325389C2 (ru) | Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью | |
| EA201171376A1 (ru) | Производные тиено[2,3-b]пиридина в качестве ингибиторов репликации вируса | |
| JP2010503695A5 (enExample) | ||
| MY154683A (en) | Pharmaceutical composition for a hepatitis c viral protease inhibitor | |
| NZ586751A (en) | Use of CDDO methyl ester (methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate) for the treatment of renal diseases and for improving kigney function | |
| CY1111159T1 (el) | Πυκνα διαλυματα μεθοτρεξατης | |
| ATE298324T1 (de) | Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| EA200870183A1 (ru) | Долговременное лечение вич-инфекции | |
| EA200800467A1 (ru) | Применение сложных эфиров гидроксибензойной кислоты и аналогов для получения лекарственного средства для предупреждения и лечения вирусной инфекции | |
| YU27203A (sh) | Pirazol derivati za tretiranje virusnih oboljenja | |
| ATE302774T1 (de) | Arzneimittel enthaltend betamimetika und ein neues anticholinergikum | |
| TW200616640A (en) | Novel pharmaceutical formulations of active principles | |
| AR045289A1 (es) | Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento | |
| CU20130013A7 (es) | El polietileno glicol conjugado de interferon alfa, representado por un isómero posicional | |
| CY1105408T1 (el) | Χρησιμοποιηση στελεχων του ιου parapox ovis για την παρασκευη αντιικων φαρμακων και φαρμακων κατα του καρκινου | |
| DE50313132D1 (de) | Pharmazeutischen zubereitungen von inhibitoren der aminopeptidase n gegebenenfalls in kombination mit inhibitoren der dipeptidylpeptidase iv zur therapie und prävention dermatologischer erkrankungen mit sebozytärer hyperproliferation und veränderten differenzierungszuständen | |
| JP2009502985A5 (enExample) | ||
| RU2007104774A (ru) | Комбинация анти-вич ингибиторов обратной транскриптазы и протеазы | |
| BRPI0407140A (pt) | Droga terapêutica para vìrus | |
| BR0116653A (pt) | Medicamento contendo uma poliamina como substância ativa | |
| EA200500418A1 (ru) | Лекарственное средство |